Currently, efficiency issues in Clinical Trials are costing between $600,000 - $8m dollars per day, and are significantly delaying the delivery of new medicine to patients in need.
We want to change that.
ClinTex are a solution provider to the pharmaceutical industry, and the team behind CTi – Clinical Trials Intelligence: a new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials.
Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry.
AS FEATURED ON:
Clinical Trials Intelligence is a distributed technology platform that incorporates predictive data analytics, machine learning (AI), and the innovative use of smart contracts to drive significant quality and operational improvements in clinical trials.
Pharmaceutical companies can now gain deep insight into the operational and clinical aspects of their trials without the necessity of major investment into backend technical infrastructure or data science expertise.
A full history of clinical trial key metrics are stored immutably on Clinical Trials Intelligence’s decentralised ledger, where they are used by Clinical Trials Intelligence’s App’s to power bespoke predictive analytics algorithms in on-going trials on the platform.
As Clinical Trials Intelligence is a fully integrated platform that provides end-to-end auditable workflow management & oversight in trials, all actions, including preventative and corrective actions (CAPA), are recorded on the Clinical Trials Intelligence blockchain on an on-going basis.
This represents the creation of a clinical eco-system that enables interoperability and safe storage of all clinical trial data views, while also addressing the privacy and security concerns of all stakeholders.
The CTi eco-system consists of seven separate Apps which each provide invaluable key insights and immense benefit to stakeholders such as Clinical Project Managers & Physicians, Clinical Data Managers, Pharmacovigilance staff and Site Monitors.
Provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff, allowing instream decision-making on what actions are required to ensure a successful project.
Clinical Data Visualisations
Provides enhanced clinical data review through the use of data visualisations to identify issues that may impact on the trial integrity and safety of the patient e.g. data quality issues, disease exacerbation. Furthermore, CTi-CDV will facilitate flagging of these issues, and corrective actions to be recorded and monitored.
The CTi-PDA application will combine all operational and clinical data sources and use predictive modelling to forecast issues and events before they happen. The CTi-PDA application will reveal hidden correlations across all datasets thereby facilitating the pharmaceutical company to take pro-active action to address.
Risk Based Monitoring
The CTi-RBM application will use current and historical data to predict specific risks, and thereby allow for tactical deployment of the pharmaceutical company’s data and site monitoring resources to take preventative action. This predictive risk based approach differs from current reactive approaches to risk and can significantly reduce site monitoring costs during a clinical trial.
Patient Recruitment and Retention
The CTi-PRR application manages recruitment and retention of patients for clinical trials by providing a portal for patient identification and producing a series of alerts (based on predictive analytics) that flag when a patient is at risk of withdrawing from the study.
The CTi-SIM application manages the recruitment of investigators (physicians) to run clinical trials,and manages token payment compensation by the pharmaceutical company to investigators, triggered by data-driven milestones and KPIs, defined on Clinical Trials Intelligence.
CTi-VMM provides oversight on data quality and manages token payment compensation by the pharmaceutical company to the third party vendors, triggered automatically by data-driven milestones and KPIs, defined on Clinical Trials Intelligence.
Combining the best of expertise from across the pharmaceutical, clinical, software development and data analytics spectrum.
Director of Operations
Brendan is a highly experienced project manager and business analyst with extensive experience in financial operations, telecommunications & consumer marketing. Successful proven leadership skills, he enjoys working with people to solve problems. Brendan has had an interest in the blockchain space since 2013 and intertwines this experience with his business expertise regularly in his role as a director in ClinTex.
Director of Clinical Data Services
Ethan is leading the Clinical Trial Services function, responsible for building partnerships with the pharmaceutical industry, and ensuring that evolving customer requirements are built into ClinTex’s products and services. Ethan has 19 years experience working directly in clinical trials including clinical data monitoring, study optimization and global operational excellence.
Director of Clinical Data Analytics
Neill leads the requirements specification, design and development of the CTi platform, ensuring it meets current and future real-world challenges for the pharmaceutical industry. He has over 20 years’ broad clinical development experience through a blend of senior roles in clinical data management, data analytics, technical/process improvement and site data monitoring.
Head of Business Development
Sean has 12 years extensive experience in the Financial Services industry and brings to the team a valuable knowledge of corporate client management, wealth management and securitisation.. His track record in the cultivation of investor and client relations will help ClinTex deliver their development roadmap and generate value for all stakeholders.
Head of Legal & Regulatory
John holds a BA (Hons) in Business Law and is a licenced solicitor in England, Wales and Ireland after being admitted into the Law Society of Ireland in 2013. John has been working in law for over eleven years and has a keen interest in all things blockchain. He is excited to be bringing his focus to the cryptocurrency legal and regulatory landscape.
Edward earned his Master of Engineering (Meng) in Dublin City University in 2007 and boosts a wealth of software engineering experience from his 10+ years’ experience in senior design roles with companies such Paddy Power Better, Citi, and Fidelity. Ed specialises in C#, Java, Python and Solidarity and his strong focus and passion for scalable solutions makes him a most welcome addition to the ClinTex team.
Technology Engineering Advisor
Sean is highly motivated software engineer with experience covering the full software development life cycle, with particular specialisation in event sourcing and CQRS. He brings excellent understanding of modern software development principles, practices and paradigms to the ClinTex advisory board.
Samandip is a physician, entrepreneur and blockchain enthusiast. Through his work with Intellimed, a government-funded AI start-up working in partnership with the largest NHS Trust in the UK, and his academic connections, Samandip will advise the ClinTex team in relation to our collaborative research grant, giving the brightest post-graduate researchers the opportunity to access the ClinTex system and fund their projects.
Intellimed is an innovative health-tech company focusing on streamlining UK National Health Service (NHS) processes, reducing costs and improving patient care. Intellimed is part of the Serendip Digital Health quarter based at the Innovation Birmingham Campus, and will be a valuable partner for CTi Platform deployments in healthcare and clinical research settings.
Global Blockchain Consortium
The GBC has been established with the mission of promoting blockchain awareness and education in the areas of fintech, disruptive tech and blockchain technologies. The GBC errand is to work in strategic collaboration with organisations and individuals that are revolutionising leading practices and wider adaptation of fintech and blockchain technologies elucidation to aid wider society.
Applicature are blockchain development agency and since 2010 have specialising in the development of smart contacts and the research, deployment, and customisation of tailored blockchain technology solutions.
Chainlink is decentralized oracle network that connects blockchain-based smart contracts to external data, payment networks, and various real-world events. Chainlink’s secure infrastructure allows smart contracts to link to APIs, in order to communicate with and obtain data from external sources such as Clinical Trial Management Systems (CTMS) and Electronic Data Capture (EDC) systems.
Sum & Substance
Sum & Substance are a pioneer in the Trusted Digital Identity space that specialise in identity proofing, risk-based authentication, regulatory identification, and the detection and prevention of the use of stolen identities, ensuring a robust and comprehensive risk and compliance solution.
Beosin is a well respected and experienced blockchain technology firm offering a full spectrum solution from tactical technical execution to high-level theoretical modelling, with a speciality in the auditing of smart contracts for blockchain projects.
Sterling Law is a modern and innovative boutique law firm with cross-domain specialisation that allows for seamless solutions to solve complex problems.
Founded in September 2017, KuCoin has grown into one of the most popular crypto exchanges, and it currently provides a series of financial services including fiat-to-crypto, crypto-to-crypto, futures, staking, borrowing, token launch and more to its 6 million users across 207 countries and regions around the world. One out of four crypto holders worldwide is with KuCoin.
The development of Clinical Trials Intelligence from concept to completion.
Ideation & Research
Development Sprint 1 ‘Minimum Viable Product’
Industry Consultation on CTi Prototype
Core Team Established
Sprint 2 ‘Enhancement’
Proof of Concept
Strategic Partnerships Agreed
CTi Data Model Finalised
CTi-OEM Prototype Development
Private Funding Rounds
CTi GUI Development
Public Token Sale
Blockchain Verification of CTi Pre-Processing Data
Migration on-chain of CTi Clinical Data Statistical Summaries
Industry Testing Pilot
Live Client On-Boarding Begins (1st Revenue)
Migration on-chain of the CTi Data Model and CTi Processing Engine